On August 6, 2025, Fractyl Health, Inc. entered into an underwriting agreement to sell 19,047,619 shares of common stock and associated warrants at a combined price of $1.05 per share, potentially raising approximately $20.7 million after expenses, with further proceeds up to $46 million possible from warrant exercises.